Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon

Strahlentherapie und Onkologie

Volumn 183, Issue 11, 2007, Pages 617-624

  Elsayed, Hassan ^a   Bölling, Tobias ^b   Moustakis, Christos ^b   Müller, Stefan Bodo ^b   Schüller, Patrick ^b   Ernst, Iris ^b   Willich, Normann ^b   Könemann, Stefan ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b NONE

Author keywords

Organ movements; Organs at risk; Prostate cancer; Rectal balloon; Three dimensional conformal radiotherapy

Indexed keywords

AGED; ARTICLE; BALLOON CATHETER; BLADDER; CANCER LOCALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; HEALTH HAZARD; HUMAN; METHODOLOGY; PROSTATE CANCER; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PROTECTION; RISK FACTOR; TELETHERAPY; THREE DIMENSIONAL IMAGING;

BRACHYTHERAPY; HUMANS; IMAGING, THREE-DIMENSIONAL; INTESTINAL MUCOSA; MALE; MOVEMENT; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIATION PROTECTION; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RECTUM; RISK; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER;

EID: 36249006842     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1736-8     Document Type: Article

References (32)

1. Artignan X, Rastkhah M, Balosso J, et al. Quantification of prostate movements during radiotherapy. Cancer Radiother. 2006;10:381-7.
2. Bakai A, Paulsen F, Plasswilm L, et al. Untersuchungen zur Positionierungsgenauigkeit bei Prostatakonformationsbestrahlungen mittels Portal-Imaging. Strahlenther Onkol 2002;178: 84-90.
3. Battermann JJ, Boon TA, Moerland MA, Results of permanent prostate brachytherapy, 13 years of experience at a single institution. Radiother Oncol 2004;71:23-8.
4. Blute ML, Bergstralh EJ, Iocca A, et al. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol 2001;165:119-25.
5. Boehmer D, Kuczer D, Badakhshi H, et al. Influence of Organ at Risk Definition on Rectal Dose-Volume Histograms in Patients with Prostate Cancer Undergoing External-Beam Radiotherapy. Strahlenther Onkol 2006;182:629-34.
6. Chen J, Morin O, Bucci MK, et al. Dose-guided radiation therapy with megavoltage cone-beam CT. Br J Radiol 2006;79 Spec No 1:87-98.
7. Ciernik IF, Baumert BG, Egli P, et al. On-line correction of beam portals in the treatment of prostate cancer using an endorectal balloon device. Radiotherapy and Oncology 2002;65:39-45.
8. De Crevoisier R, Lagrange JL, Messai T, et al. Prostate localization systems for prostate radiotherapy. Cancer Radiother 2006;10:394-401.
9. El-Bassiouni M, Davis JB, El-Attar I, et al. Target Motion Variability and On-Line Positioning Accuracy during External-Beam Radiation Therapy of Prostate Cancer with an Endorectal Balloon Device. Strahlenther Onkol 2006;182:531-6.
10. Galalae RM, Loch T, Riemer B, et al. Health-related quality of life measurement in long-term survivors and outcome following radical radiotherapy for localized prostate cancer. Strahlenther Onkol 2004;180:582-9.
11. Gerber GS, Thisted RA, Scardino PT, et al. Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA 1996;276:1723-4.
12. Gerstner N, Wachter S, Dorner D, et al. Significance of a rectal balloon as internal immobilization device in conformal radiotherapy of prostatic carcinoma. Strahlenther Onkol 1999;175:232-8.
13. Goldner G, Geinitz H, Wachter S, et al. 3-D Conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: a prospective study of patients' acceptance of the rectal balloon during treatment. Wien Klin Wochenschr 2006;118:224-9.
14. Goldner G, Wachter-Gerstner N, Wachter S. et al. Acute Side Effects during 3-D-Planned Conformal Radiotherapy of Prostate Cancer. Strahlenther Onkol 2003;179:320-7.
15. Guckenberger M, Flentje M. Intensity-Modulated Radiotherapy (IMRT) of localized Prostate Cancer. Strahlenther Onkol 2007;183:57-62.
16. Guckenberger M, Pohl F, Baier K, et al. Influence of Rectum Delineation (Rectal Volume vs. Rectal Wall) on IMRT Treatment Planning of the Prostate. Strahlenther Onkol 2006;182:721-6.
17. Han M, Partin AW, Zahurak M, et al. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003;169:517-23.
18. Hanks GE. Conformal radiotherapy for prostate cancer. Ann Med 2000;32:57-63.
19. Hille A, Schmidberger H, Töws N, et al. The impact of varying volumes in rectal balloons on rectal dose sparing in conformal radiation therapy of prostate cancer. A prospective three-dimensional analysis. Strahlenther Onkol 2005;181:709-16.
20. Hille A, Töws N, Schmidberger H, et al. A Prospective Three-Dimensional Analysis about the Impact of Differences in the Clinical Target Volume in Prostate Cancer Irradiation on Normal-Tissue Exposure. Strahlenther Onkol 2005;181:789-95.
21. Hurkmans CW, Remeijer P, Lebesque JV, et al. Set-up verification using portal imaging; review of current clinical practice. Radiother Oncol 2001;58:105-20.
22. Kaulich TW, Lamprecht U, Paulsen F, et al. Physical basics and clinical realization of interstitial brachytherapy of the prostate with iodine 125. Strahlenther Onkol 2002;178:548-55.
23. Oldham M, Letourneau D, Watt L, et al. Cone-beam-CT guided radiation therapy: A model for online application. Radiother Oncol 2005;75:271-8.
24. Patel RR, Orton N, Tomè WA, et al. Rectal dose sparing with a ballon catheter and ultrasound localization in conformal radiation therapy for prostate cancer. Radiother Oncol 2003;67:285-94.
25. Rudat V, Flentje M, Oetzel D, et al. Influence of the positioning error on 3D conformal dose distributions during fractionated radiotherapy. Radiother Oncol 1994; 33:56-63.
26. Sandler HM, Dunn RL, McLaughlin PW, et al. Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy. Int J Radiat Oncol Biol Phys 2000;48:629-33.
27. Smitsmans MH, Wolthaus JW, Artignan X, et al. Automatic localization of the prostate for on-line or off-line image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:623-35.
28. Teh BS, McGary JE, Dong L, et al. The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device? Cancer J 2002;8:476-83.
29. Thilmann C, Nill S, Tucking T, et al. Correction of patient positioning errors based on in-line cone beam CTs: clinical implementation and first experiences. Radiat Oncol 2006;1:16.
30. Wachter S, Gerstner N, Dorner D, et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;52:91-100.
31. Yoo S, Yin FF. Dosimetric feasibility of cone-beam CT-based treatment planning compared to CT-based treatment planning. Int J Radiat Oncol Biol Phys 2006;66:1553-61.
32. Zelefsky MJ, Chan H, Hunt M, et al. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 2006;176:1415-9.